Your browser doesn't support javascript.
loading
Netrin-1 promotes the vasculogenic capacity of human adipose-derived stem cells.
Luo, Ming-Lian; Zhu, Jian-Wen; Gao, Xue-Mei.
Afiliação
  • Luo ML; Department of Obstetrics and Gynecology, Wuhan NO.1 Hospital, Wuhan, 430030, Hu Bei, China.
  • Zhu JW; Department of Obstetrics and Gynecology, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, 430030, Hu Bei, China.
  • Gao XM; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Cell Tissue Bank ; 24(2): 357-367, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36222969
ABSTRACT
Adipose derived stem cells (ADSCs) have been increasingly explored for use in cell-based therapy against ischemic diseases. However, unsatisfactory angiogenesis limits the therapeutic efficacy. Netrin-1, a known axon guidance molecule, improves neovascularization in the ischemic region. Thus, our study was performed to evaluate the potential effect of Netrin-1 on the angiogenic behaviors of human ADSCs (hADSCs). hADSCs acquired from human abdominal adipose tissue were modified by liposome transfection of Netrin-1 plasmid, and the proliferation of hADSCs was determined by Cell Counting Kit-8 (CCK-8) assay. The transcript levels of pro-invasive proteins such as matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP-9), were measured to test migratory and invasive capabilities, and the levels of vascular endothelial growth factors were assayed to monitor angiogenic activity. Our results showed that Netrin-1 overexpression enhanced the proliferation of hADSCs, and promoted the migration and invasion of hADSCs, as indicated by increased levels of MMP-2 and MMP-9. Furthermore, Netrin-1 overexpression increased the expression of vascular endothelial growth factor and placental growth factor in hADSCs. Our results highlighted the possibility that genetic modification of hADSCs by Netrin-1 overexpression might be beneficial for cell transplantation therapy against ischemic diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metaloproteinase 2 da Matriz / Metaloproteinase 9 da Matriz Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metaloproteinase 2 da Matriz / Metaloproteinase 9 da Matriz Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article